Page last updated: 2024-10-23

azathioprine and Placental Insufficiency

azathioprine has been researched along with Placental Insufficiency in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Placental Insufficiency: Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G1
Crispin, P1
Cherian, M1
Dahlstrom, JE1
Sethna, FF1
Kaye, G1
Pavli, P1
Subramaniam, K1

Other Studies

1 other study available for azathioprine and Placental Insufficiency

ArticleYear
Placental involvement by non-Hodgkin lymphoma in a Crohn disease patient on long-term thiopurine therapy.
    Internal medicine journal, 2016, Volume: 46, Issue:1

    Topics: Adult; Azathioprine; Crohn Disease; Female; Fetal Death; Humans; Lymphoma, Non-Hodgkin; Placenta; Pl

2016